Clave Capital | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Clave Capital/Activity

Clave Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

New Fund

Launching a new €80M fund for health technology transfer (medtech, eHealth, nutrition, biotech), with CDTI committing up to €40M through its INNVIERTE instrument.

New €80M fund for health tech transfer

Added recently

3 investments

· MAY 2023 – SEP 2026

Show all

Investment

Led a €3.1M financing round in Connecta Therapeutics via the Innvierte Science Tech Clave Innohealth fund to advance its Fragile X syndrome drug program.

Connecta Therapeutics

Connecta Therapeutics Clave Capital

expansion.comSEP 10, 2026

SEP 10, 2026

Investment

Led Nanological's €600K first financing round through the Clave Innohealth fund.

Nanological

Nanological Clave Capital

elreferente.esNOV 22, 2023

NOV 22, 2023

Investment

Invested €1M in D-Sight, a VHIR spin-off, through the Clave Innohealth fund.

D-Sight

D-Sight Clave Capital

pcb.ub.eduMAY 4, 2023

MAY 4, 2023